Intarcia names a COO and ITCA 650 launch chief; Can-Fite sub buys an Israeli company;

@FierceBiotech: A gene therapy 'cure' for blindness starts to fade within a few years. Report | Follow @FierceBiotech

@JohnCFierce: Pharma wants to avoid "Gilead's gaffe"? Really? I assume you mean they want to avoid the controversy, keep the $$$. More | Follow @JohnCFierce

> Boston-based Intarcia Therapeutics named Michael Williams to the newly created role of chief operating officer. The Takeda vet will be responsible for "commercial capabilities and operational plans for ITCA 650," its once or twice-yearly drug/device for diabetes. Release

> Israel's Can-Fite ($CANF) says its subsidiary OphthaliX (OTCQB: OPLI) has signed a nonbinding term sheet to acquire Israel-based Improved Vision Systems. Release

Medical Device News

@FierceMedDev: ICYMI: Greatbatch spins off neurostimulation unit to speed up growth. Report | Follow @FierceMedDev

@VarunSaxena2: ICYMI from FierceDiagnostics: Drug testing company Cordant raises $12.8M as it seeks to be fragmented industry's one-stop shop. Story | Follow @VarunSaxena2

@EmilyWFierce: Novartis faces more kickback scrutiny after $45M Express Scripts settlement. FiercePharma story | Follow @EmilyWFierce

> China launches probe against three med tech multinationals over bribery suspicions. Story

> Under FDA investigation, Bayer releases new data on Essure contraceptive with a positive twist. Article

Pharma News

@FiercePharma: Busy WuXi starts construction on China's largest biologics manufacturing plant. FiercePharmaAsia article | Follow @FiercePharma

@EricPFierce: Drug shortages become way for Mylan to parry against Teva but will the FTC care? ICYMI from FiercePharmaManufacturing | Follow @EricPFierce

> Pfizer's Viagra keeps generics at bay in China, with sales up 47%. Story

> Did Medicare really spend so much on Nexium? Not after rebates. Article

Animal Health News

> VCA animal hospitals report higher Q1 earnings. More

> Missouri scientists seek public's help in quest to sequence feline genomes. Report

> IDEXX misses earnings target, dampens 2015 forecast. Story

> Chicken producer Tyson to ditch human antibiotics in 2017. Item

> High-flyer Akorn crashes on earnings restatement as shareholders sue en masse. Article

Biotech IT News

> Genentech joins WaferGen's single cell analysis early-access program. Item

> GSK's social media savvy bags it 2nd place in digital ranking of big British businesses. More

> Apple Watch's data-gathering functions fall short of expectations. Story

> California calls for precision medicine pilot proposals. Report

> Congress keeps trial data sharing plan in slimmed-down 21st Century Cures Act. Article

Suggested Articles

A patient has died in the global study of AstraZeneca’s COVID-19 vaccine, Brazil’s health authority, Anvisa, announced on Wednesday.

MyoKardia wasn’t looking for a buyout when it started discussing potential partnerships with Bristol Myers Squibb last year.

The patient was hospitalized with febrile neutropenia in the weeks after receiving the drug and died 52 days post-treatment with the CAR-T therapy.